# Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients

> **NCT03422861** · NA · UNKNOWN · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Nabilone
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03422861
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422861, "Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03422861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*